/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Amy Whitehead

University Hospital Southampton NHS Foundation Trust(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

31

Papers

5.1K

Citations

14

h-index

16

i10-index

Amy Whitehead is an academic researcher from University Hospital Southampton NHS Foundation Trust. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Meta-analysis and systematic reviews & Statistical Methods in Clinical Trials. The author has an h-index of 14, co-authored 27 publications.

ORCID: 0000-0002-2840-6876

Research Topics

Health Systems, Economic Evaluations, Quality of Life Meta-analysis and systematic reviews Statistical Methods in Clinical Trials Prostate Cancer Treatment and Research Hepatocellular Carcinoma Treatment and Prognosis

Papers by this author

works

Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable

2015 · Statistical Methods in Medical Research · 1,749 citations

https://doi.org/10.1177/0962280215588241

Amy Whitehead Steven A. Julious Cindy Cooper Michael J. Campbell

An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database

2013 · BMC Medical Research Methodology · 906 citations

https://doi.org/10.1186/1471-2288-13-104

Sophie Billingham Amy Whitehead Steven A. Julious

Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study

2014 · Trials · 748 citations

https://doi.org/10.1186/1745-6215-15-264

M. Dawn Teare Munyaradzi Dimairo Neil Shephard Alex Hayman

Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

2022 · Trials · 23 citations

https://doi.org/10.1186/s13063-022-06132-z

Hugh Gallagher Jennifer Dumbleton Tom Maishman Amy Whitehead

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

2018 · Trials · 11 citations

https://doi.org/10.1186/s13063-018-2586-7

Simon J. Crabb Sarah Danson James W.F. Catto Cathy McDowell

Sample size requirements for pilot randomised controlled trials with binary outcomes: a simulation study

2013 · Trials · 10 citations

https://doi.org/10.1186/1745-6215-14-s1-o21

M. Dawn Teare Munyaradzi Dimairo Alexandra Hayman Neil Shephard

Research topics

topics

Health Systems, Economic Evaluations, Quality of Life

Meta-analysis and systematic reviews

Statistical Methods in Clinical Trials

Prostate Cancer Treatment and Research

Hepatocellular Carcinoma Treatment and Prognosis

Chat about Author

Papers

Chat

Click to start Chat